These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 3698528)

  • 1. [Treatment of chronic cerebrovascular insufficiency: comparison of nimodipine and dihydroergotoxine].
    Cosmi F; Caresia L; Panebianco G
    Clin Ter; 1986 Feb; 116(3):213-20. PubMed ID: 3698528
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of chronic cerebrovascular insufficiency. Controlled comparative study of 2 cerebral antihypoxidosis agents].
    Szobor A; Klein M; Bräuer H
    MMW Munch Med Wochenschr; 1982 Oct; 124(41):897-900. PubMed ID: 6815511
    [No Abstract]   [Full Text] [Related]  

  • 3. [Double-blind study based upon a quatitative appreciation scale of treating chronic cerebrovascular disorders].
    Mémin Y; Najean Hueber E
    Therapeutique; 1973 Nov; 49(9):605-8. PubMed ID: 4600040
    [No Abstract]   [Full Text] [Related]  

  • 4. Cerebral vasodilators (second of two parts).
    Cook P; James I
    N Engl J Med; 1981 Dec; 305(26):1560-4. PubMed ID: 7031468
    [No Abstract]   [Full Text] [Related]  

  • 5. [Combined therapy with vasodilator and lipid-clearing drugs in cerebrovascular insufficiency in advanced old age].
    Giovanardi F; Bisceglia G
    Clin Ter; 1971 Aug; 58(3):243-53. PubMed ID: 5135003
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the therapy of cerebral and peripheral circulatory disorders].
    Klein L
    Med Welt; 1969 Aug; 35():1913-6. PubMed ID: 4390197
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of cerebrovascular insufficiency].
    Cosentino F; Baldassarri R
    Clin Ter; 1979 Mar; 88(6):631-8. PubMed ID: 380878
    [No Abstract]   [Full Text] [Related]  

  • 8. Drugs for dementia.
    Drug Ther Bull; 1975 Oct; 13(22):85-7. PubMed ID: 1102280
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic action of vasodilator drugs in chronic cerebrovascular insufficiency].
    Chacón Peña J; Castellanos Mateos F
    Rev Clin Esp; 1978 Oct; 151(2):165-70. PubMed ID: 740988
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experiences with Card-hydergine in patients with cardiac insufficiency and cerebrovascular disorders in professional practice].
    Kohler H
    Med Monatsschr; 1976 Nov; 30(11):516-8. PubMed ID: 792670
    [No Abstract]   [Full Text] [Related]  

  • 11. [A delayed-action therapeutic agent in chronic cerebral circulatory insufficiencies].
    Boudouresques J; Papy JJ; Daniel F
    Therapeutique; 1970 Oct; 46(8):789-92. PubMed ID: 5458910
    [No Abstract]   [Full Text] [Related]  

  • 12. [Indications for and effects of vasodilating agents, especially in cerebral and peripheral vascular sclerosis].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1981 Feb; 125(6):228-34. PubMed ID: 7207673
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dihydroergotoxine mesylate in chronic cerebrovascular insufficiency: spectral EEG analysis and neuropsychological correlates].
    Moglia A; Bono G; Sinforiani E; Alfonsi E; Zandrini C; Pistarini C; Arrigo A; Franch F
    Farmaco Prat; 1983 Feb; 38(2):97-102. PubMed ID: 6832350
    [No Abstract]   [Full Text] [Related]  

  • 14. [The vasoactivogram in the treatment of peripheral arteriopathies].
    Romeo S; Spinella G; Sciacchitanto D
    Angiologia; 1975; 27(1):7-25. PubMed ID: 1111377
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of cardiac and cerebrovascular insufficiency with Card-Cosaldon. Result of a field study].
    Koeppen G; Schmidt-Modrow G
    Ther Ggw; 1979 Nov; 118(11):1704-13. PubMed ID: 538738
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical evaluation of (-) eburnamonine in chronic cerebrovascular insufficiency].
    De Pergola E; Di Lorenzo L; De Pergola G
    G Clin Med; 1980 Aug; 61(8):628-42. PubMed ID: 7004986
    [No Abstract]   [Full Text] [Related]  

  • 17. [The treatment of blood circulation disorders with an adenosine-theophylline sodium nicotinate combination].
    Hüdepohl M; Bockelmann R
    Med Klin; 1966 Feb; 61(5):184-6. PubMed ID: 5982907
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical trials with dihydroergocristine in patients with vascular and cerebral insufficiency].
    Ingelmo M; Vivancos J; Peri J; Balcells Gorina A
    Rev Clin Esp; 1980 Dec; 159(6):399-402. PubMed ID: 6784197
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experience with the medical treatment of chronic cerebrovascular insufficiency: bamethan and inositol nicotinate versus placebo].
    Cucinotta D; Silvestrini C; Mancini M; Maini C; Passeri M
    G Clin Med; 1981 May; 62(5):339-50. PubMed ID: 6115790
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinico-hemodynamic evaluation of the efficacy of vasoactive and cardiotonic agents in the combined treatment of arteriosclerosis patients with chronic cerebral circulatory insufficiency].
    Ishchenko MM; Dorogiĭ AN; Nechaĭ EE; Shkrobot SI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(9):1313-20. PubMed ID: 3425072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.